Quarterly report · Q2
6776.TEDINET S100PKUV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥19.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥266m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥19m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥445m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥355m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥81m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥464m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥92m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥329m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥246m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥311m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥37m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥23.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥21.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.9bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.9bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥13.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥472m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥831m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥456m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥544m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥545m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥399m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.39 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.23 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.47 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.23 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.66 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥26m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥430m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥389m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥40m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥107m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥117m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥59m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥263m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥19m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥3m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥51m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥222m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥221m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥17m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥7.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥7.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥17m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥163m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥144m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥144m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥117m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥8.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥8.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥19m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥22m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 501
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 222000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 1190000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | 144000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 8639000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -19000000 | JPY |
| Net sales | Prior1YTDDuration | 8620000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | -163000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 17000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 51000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | 117000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 22000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -3000000 | JPY |
| Operating income | Prior1YTDDuration | 19000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 9060000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 389000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 1303000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | 143000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 10896000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 10896000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 18000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 40000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 59000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -59000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 9078000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 430000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 1303000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | 143000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 10955000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -59000000 | JPY |
| Net sales | CurrentYTDDuration | 10896000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 107000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 65000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | -26000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01813-000RealEstateBusinessReportableSegmentsMember | 117000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 263000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 2000000 | JPY |
| Operating income | CurrentYTDDuration | 266000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第97期第２四半期（自 2022年７月１日 至 2022年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)天昇電気工業株式会社 | |
| Company name in english cover page | FilingDateInstant | Tensho Electric Industries Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)取締役社長 石 川 忠 彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都町田市南町田五丁目３番65号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |